LBEL REPLENISHING FOUNDATION SPF 14 description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

LBEL REPLENISHING FOUNDATION SPF 14

Ventura Corporation LTD

L'BEL REPLENISHING FOUNDATION SPF 14


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active Ingredients

Octinoxate (4.5 %)

Purpose

Sunscreen

LBEL REPLENISHING FOUNDATION SPF 14 Uses

  • Helps prevent sunburn.

Warnings

  • Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
  • For external use only.
  • Do not use on damaged or broken skin.
  • When using this product keep out of eyes. Rinse with water to remove.
  • Stop use and ask a doctor if rash occurs.
  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Apply liberally and evenly 15 minutes before sun exposure.
  • Reapply at least every 2 hours
  • Use a water resistant sunscreen if swimming or sweating.
  • Children under 6 months of age: Ask a doctor
  • Apply to the forehead, nose, chin and both cheeks.
    Blend with CIrcular motion and spread softly without stretching the skin.

LBEL REPLENISHING FOUNDATION SPF 14 Other information

  • Protect the product in this container from excessive heat and direct sun.

Inactive ingredients

Water, cyclopentasiloxane, butylene glycol, cyclohexasiloxane, phenyl trimethicone, cetyl peg/ppg-10/1 dimethicone, polyglyceryl-4 isostearate, nylon-12 fluorescent brightener 230 salt, hexyl laurate, mannitol, glycerin, ethylene/acrylic acid copolymer, glycine soja (soybean) protein, peg/ppg-18/18 dimethicone, disteardimonium hectorite, sodium chloride, dimethicone, propylene glycol, dimethicone crosspolymer, dimethicone/vinyl dimethicone crosspolymer, diazolidinyl urea, hydrolyzed keratin, dimethiconol, sucrose, methylparaben, serine, fragrance, arginine, cyclodextrin, polyvinylalcohol crosspolymer, pca, bht, macrocystis pyrifera extract, yeast extract, alanine, propylparaben, hydrolyzed wheat protein, carbomer, pvp, threonine, polysorbate 20, disodium succinate, mourera fluviatilis extract, palmitoyl pentapeptide-4.

May contain: titanium dioxide, iron oxides, iron oxides, iron oxides,methicone.

PR: Distributed by Ventura Corporation, Ltd. San Juan, Puerto Rico 00926.

PRINCIPAL DISPLAY PANEL - 30 g Bottle Box - Claire 1 - BEIGE

L'BEL

replenishing foundation SPF 14

Net Weight 1 oz. (30 g)

LBEL REPLENISHING FOUNDATION SPF 14

PRINCIPAL DISPLAY PANEL - 30 g Bottle Box - Claire 2 - BEIGE

L'BEL

replenishing foundation SPF 14

Net Weight 1 oz. (30 g)

LBEL REPLENISHING FOUNDATION SPF 14

PRINCIPAL DISPLAY PANEL - 30 g Bottle Box - Claire 3 - BEIGE

L'BEL

replenishing foundation SPF 14

Net Weight 1 oz. (30 g)

LBEL REPLENISHING FOUNDATION SPF 14

PRINCIPAL DISPLAY PANEL - 30 g Bottle Box - Claire 4 - BEIGE

L'BEL

replenishing foundation SPF 14

Net Weight 1 oz. (30 g)

LBEL REPLENISHING FOUNDATION SPF 14

PRINCIPAL DISPLAY PANEL - 30 g Bottle Box - Medium 5 - BROWN

L'BEL

replenishing foundation SPF 14

Net Weight 1 oz. (30 g)

LBEL REPLENISHING FOUNDATION SPF 14

PRINCIPAL DISPLAY PANEL - 30 g Bottle Box - Medium 6 - BROWN

L'BEL

replenishing foundation SPF 14

Net Weight 1 oz. (30 g)

LBEL REPLENISHING FOUNDATION SPF 14

PRINCIPAL DISPLAY PANEL - 30 g Bottle Box - Medium 7 - BROWN

L'BEL

replenishing foundation SPF 14

Net Weight 1 oz. (30 g)

LBEL REPLENISHING FOUNDATION SPF 14

PRINCIPAL DISPLAY PANEL - 30 g Bottle Box - Obscure 8 - BROWN

L'BEL

replenishing foundation SPF 14

Net Weight 1 oz. (30 g)

LBEL REPLENISHING FOUNDATION SPF 14

PRINCIPAL DISPLAY PANEL - 30 g Bottle Box - Obscure 9 - BROWN

L'BEL

replenishing foundation SPF 14

Net Weight 1 oz. (30 g)

LBEL REPLENISHING FOUNDATION SPF 14

LBEL REPLENISHING FOUNDATION SPF 14

Octinoxate LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-257
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.045 g

Inactive Ingredients

Ingredient Name Strength
water
CYCLOMETHICONE 5
BUTYLENE GLYCOL
CYCLOMETHICONE 6
PHENYL TRIMETHICONE
POLYGLYCERYL-4 ISOSTEARATE
HEXYL LAURATE
mannitol
GLYCERIN
PEG/PPG-18/18 DIMETHICONE
DISTEARDIMONIUM HECTORITE
SODIUM CHLORIDE
DIMETHICONE
propylene glycol
DIAZOLIDINYL UREA
SUCROSE
METHYLPARABEN
SERINE
ARGININE
PIDOLIC ACID
BUTYLATED HYDROXYTOLUENE
MACROCYSTIS PYRIFERA
yeast
ALANINE
PROPYLPARABEN
THREONINE
POLYSORBATE 20
sodium succinate anhydrous
PALMITOYL PENTAPEPTIDE-4
titanium dioxide
ferric oxide red

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-257-01 30 in 1 BOTTLE
2 NDC:13537-257-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-12-16


LBEL REPLENISHING FOUNDATION SPF 14

Octinoxate LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-258
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.045 g

Inactive Ingredients

Ingredient Name Strength
water
CYCLOMETHICONE 5
BUTYLENE GLYCOL
CYCLOMETHICONE 6
PHENYL TRIMETHICONE
POLYGLYCERYL-4 ISOSTEARATE
HEXYL LAURATE
mannitol
GLYCERIN
PEG/PPG-18/18 DIMETHICONE
DISTEARDIMONIUM HECTORITE
SODIUM CHLORIDE
DIMETHICONE
propylene glycol
DIAZOLIDINYL UREA
SUCROSE
METHYLPARABEN
SERINE
ARGININE
PIDOLIC ACID
BUTYLATED HYDROXYTOLUENE
MACROCYSTIS PYRIFERA
yeast
ALANINE
PROPYLPARABEN
THREONINE
POLYSORBATE 20
sodium succinate anhydrous
PALMITOYL PENTAPEPTIDE-4
titanium dioxide
ferric oxide red

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-258-03 30 in 1 BOTTLE
2 NDC:13537-258-04 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-12-16


LBEL REPLENISHING FOUNDATION SPF 14

Octinoxate LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-259
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.045 g

Inactive Ingredients

Ingredient Name Strength
water
CYCLOMETHICONE 5
BUTYLENE GLYCOL
CYCLOMETHICONE 6
PHENYL TRIMETHICONE
POLYGLYCERYL-4 ISOSTEARATE
HEXYL LAURATE
mannitol
GLYCERIN
PEG/PPG-18/18 DIMETHICONE
DISTEARDIMONIUM HECTORITE
SODIUM CHLORIDE
DIMETHICONE
propylene glycol
DIAZOLIDINYL UREA
SUCROSE
METHYLPARABEN
SERINE
ARGININE
PIDOLIC ACID
BUTYLATED HYDROXYTOLUENE
MACROCYSTIS PYRIFERA
yeast
ALANINE
PROPYLPARABEN
THREONINE
POLYSORBATE 20
sodium succinate anhydrous
PALMITOYL PENTAPEPTIDE-4
titanium dioxide
ferric oxide red

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-259-05 30 in 1 BOTTLE
2 NDC:13537-259-06 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-12-16


LBEL REPLENISHING FOUNDATION SPF 14

Octinoxate LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-260
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.045 g

Inactive Ingredients

Ingredient Name Strength
water
CYCLOMETHICONE 5
BUTYLENE GLYCOL
CYCLOMETHICONE 6
PHENYL TRIMETHICONE
POLYGLYCERYL-4 ISOSTEARATE
HEXYL LAURATE
mannitol
GLYCERIN
PEG/PPG-18/18 DIMETHICONE
DISTEARDIMONIUM HECTORITE
SODIUM CHLORIDE
DIMETHICONE
propylene glycol
DIAZOLIDINYL UREA
SUCROSE
METHYLPARABEN
SERINE
ARGININE
PIDOLIC ACID
BUTYLATED HYDROXYTOLUENE
MACROCYSTIS PYRIFERA
yeast
ALANINE
PROPYLPARABEN
THREONINE
POLYSORBATE 20
sodium succinate anhydrous
PALMITOYL PENTAPEPTIDE-4
titanium dioxide
ferric oxide red

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-260-07 30 in 1 BOTTLE
2 NDC:13537-260-08 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-12-16


LBEL REPLENISHING FOUNDATION SPF 14

Octinoxate LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-298
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.045 g

Inactive Ingredients

Ingredient Name Strength
water
CYCLOMETHICONE 5
BUTYLENE GLYCOL
CYCLOMETHICONE 6
PHENYL TRIMETHICONE
POLYGLYCERYL-4 ISOSTEARATE
HEXYL LAURATE
mannitol
GLYCERIN
PEG/PPG-18/18 DIMETHICONE
DISTEARDIMONIUM HECTORITE
SODIUM CHLORIDE
DIMETHICONE
propylene glycol
DIAZOLIDINYL UREA
SUCROSE
METHYLPARABEN
SERINE
ARGININE
PIDOLIC ACID
BUTYLATED HYDROXYTOLUENE
MACROCYSTIS PYRIFERA
yeast
ALANINE
PROPYLPARABEN
THREONINE
POLYSORBATE 20
sodium succinate anhydrous
PALMITOYL PENTAPEPTIDE-4
titanium dioxide
ferric oxide red

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-298-09 30 in 1 BOTTLE
2 NDC:13537-298-10 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-12-16


LBEL REPLENISHING FOUNDATION SPF 14

Octinoxate LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-262
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.045 g

Inactive Ingredients

Ingredient Name Strength
water
CYCLOMETHICONE 5
BUTYLENE GLYCOL
CYCLOMETHICONE 6
PHENYL TRIMETHICONE
POLYGLYCERYL-4 ISOSTEARATE
HEXYL LAURATE
mannitol
GLYCERIN
PEG/PPG-18/18 DIMETHICONE
DISTEARDIMONIUM HECTORITE
SODIUM CHLORIDE
DIMETHICONE
propylene glycol
DIAZOLIDINYL UREA
SUCROSE
METHYLPARABEN
SERINE
ARGININE
PIDOLIC ACID
BUTYLATED HYDROXYTOLUENE
MACROCYSTIS PYRIFERA
yeast
ALANINE
PROPYLPARABEN
THREONINE
POLYSORBATE 20
sodium succinate anhydrous
PALMITOYL PENTAPEPTIDE-4
titanium dioxide
ferric oxide red

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-262-11 30 in 1 BOTTLE
2 NDC:13537-262-12 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-12-16


LBEL REPLENISHING FOUNDATION SPF 14

Octinoxate LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-263
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.045 g

Inactive Ingredients

Ingredient Name Strength
water
CYCLOMETHICONE 5
BUTYLENE GLYCOL
CYCLOMETHICONE 6
PHENYL TRIMETHICONE
POLYGLYCERYL-4 ISOSTEARATE
HEXYL LAURATE
mannitol
GLYCERIN
PEG/PPG-18/18 DIMETHICONE
DISTEARDIMONIUM HECTORITE
SODIUM CHLORIDE
DIMETHICONE
propylene glycol
DIAZOLIDINYL UREA
SUCROSE
METHYLPARABEN
SERINE
ARGININE
PIDOLIC ACID
BUTYLATED HYDROXYTOLUENE
MACROCYSTIS PYRIFERA
yeast
ALANINE
PROPYLPARABEN
THREONINE
POLYSORBATE 20
sodium succinate anhydrous
PALMITOYL PENTAPEPTIDE-4
titanium dioxide
ferric oxide red

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-263-13 30 in 1 BOTTLE
2 NDC:13537-263-14 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-12-16


LBEL REPLENISHING FOUNDATION SPF 14

Octinoxate LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-264
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.045 g

Inactive Ingredients

Ingredient Name Strength
water
CYCLOMETHICONE 5
BUTYLENE GLYCOL
CYCLOMETHICONE 6
PHENYL TRIMETHICONE
POLYGLYCERYL-4 ISOSTEARATE
HEXYL LAURATE
mannitol
GLYCERIN
PEG/PPG-18/18 DIMETHICONE
DISTEARDIMONIUM HECTORITE
SODIUM CHLORIDE
DIMETHICONE
propylene glycol
DIAZOLIDINYL UREA
SUCROSE
METHYLPARABEN
SERINE
ARGININE
PIDOLIC ACID
BUTYLATED HYDROXYTOLUENE
MACROCYSTIS PYRIFERA
yeast
ALANINE
PROPYLPARABEN
THREONINE
POLYSORBATE 20
sodium succinate anhydrous
PALMITOYL PENTAPEPTIDE-4
titanium dioxide
ferric oxide red

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-264-15 30 in 1 BOTTLE
2 NDC:13537-264-16 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-12-16


LBEL REPLENISHING FOUNDATION SPF 14

Octinoxate LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:13537-265
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.045 g

Inactive Ingredients

Ingredient Name Strength
water
CYCLOMETHICONE 5
BUTYLENE GLYCOL
CYCLOMETHICONE 6
PHENYL TRIMETHICONE
POLYGLYCERYL-4 ISOSTEARATE
HEXYL LAURATE
mannitol
GLYCERIN
PEG/PPG-18/18 DIMETHICONE
DISTEARDIMONIUM HECTORITE
SODIUM CHLORIDE
DIMETHICONE
propylene glycol
DIAZOLIDINYL UREA
SUCROSE
METHYLPARABEN
SERINE
ARGININE
PIDOLIC ACID
BUTYLATED HYDROXYTOLUENE
MACROCYSTIS PYRIFERA
yeast
ALANINE
PROPYLPARABEN
THREONINE
POLYSORBATE 20
sodium succinate anhydrous
PALMITOYL PENTAPEPTIDE-4
titanium dioxide
ferric oxide red

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13537-265-17 30 in 1 BOTTLE
2 NDC:13537-265-18 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-12-16


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.